Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Congress Wrap: EHA 2025
July 2025
Our wrap-up video captures all the key moments from the European Hematology Association (EHA) Congress 2025, watch now
Read more
13 Dec 2023
Autologous Transplant or Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Large B-cell Lymphoma: How to Choose?
Expert Madiha Iqbal, Consultant and Assistant Professor of Medicine, Mayo Clinic, Jacksonville, Florida, USA, presents on the treatment…
27 Sep 2023
Update on Challenges in Diagnosis and Treatment of Myeloid Neoplasms with Systemic Mastocytosis
Concurrent systemic mastocytosis (SM) may often be missed in patients with myeloid neoplasms, such as, chronic myelomonocytic…
19 Jul 2023
Chronic Lymphocytic Leukemia (CLL) and Beyond: Management of the Infection Burden
The overall survival of patients with chronic lymphocytic leukemia (CLL) has improved significantly over the years; however, the clinical…
12 Jul 2023
Evolving the treatment paradigm in cold agglutinin disease (CAD): Challenges and opportunities for optimal management
Prof. Alexander Röth (Chair), Prof. Wilma Barcellini, Prof. Josephine Vos and Prof. Bernd Jilma, will discuss about the evolving treatment paradigm in cold agglutinin disease (CAD): challenges and opportunities for optimal management.
11 Jul 2023
What to do when CAR Ts are not the most appropriate option in 2L DLBCL: Current treatment options for transplant-ineligible patients
An innovative session highlighting patient-focused decision-making and a dynamic debate on current 2L DLBCL treatment options.
20 Mar 2023
Updates on CAR-NK Cells
This presentation offers insight into chimeric antigen receptor-transduced (CAR) natural killer (NK) cells, providing an update on the involvement of these cells in a host of topics, from stem cell transplantation to cancer.
27 Feb 2023
Update on AL Amyloidosis
This webinar discusses the critical factors involved in amyloidosis diagnosis, prognosis and management, describing both haematologic and organ responses to treatment. The presentation also delves into the origins of cardiac amyloidosis, outlining investigations required to assess organ involvement and establish a diagnosis.
28 Nov 2022
DOACs in Review - How did we get here?
This upcoming webinar discussion shares clinical insights from an expert in the use of direct oral anticoagulants for the treatment of…
Loading posts...
« Previous
1
2
3
4
5
…
9
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View